Advit Jewels shares made a blockbuster stock market debut on Wednesday, listing at up to a 36% premium over the IPO price after the issue w...

Guo Wengui, the Self-exiled Chinese businessman, has been sentenced to 30 years in prison for orchestrating a massive fraud scheme. Prosecu...

Alembic Pharmaceuticals has secured final USFDA approval for its generic Dapsone gel, a topical treatment for acne vulgaris. This approval,...

Anubhav Plast shares debuted at their IPO price of Rs 80 on the BSE SME platform, mirroring grey market expectations. The company's Rs 80 c...

Turtlemint Fintech Solutions experienced a subdued market debut, with shares listing at a discount to their IPO price on both NSE and BSE. ...

Indian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving average...

The interesting point about the large-cap space today is not that prices have collapsed. In most cases, they have not. The more important c...

AI giant OpenAI is reportedly eyeing a 2027 initial public offering, potentially after rival Anthropic. Both companies have confidentially ...

Cargo drone startup Elroy Air is set to go public in the US through a $1 billion merger with blank-check firm Columbus Circle Capital Corp ...

Alembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for influenza. Th...

Indian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatm...

Indian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...

Indian stock markets are defying foreign investor caution, driven by resilient June-quarter earnings. Companies are navigating geopolitical...

Honasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's ...

Healthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...

Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...

Indian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...